Salvage Systemic Therapy for Advanced Urothelial Carcinoma: On the Cusp of a Sea Change?

Oncologist - United States
doi 10.1634/theoncologist.2015-0077
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Alphamed Press

Related search

Molecular Signature of Response to Pazopanib Salvage Therapy for Urothelial Carcinoma

Clinical Genitourinary Cancer
OncologyUrology
2016English

Cisplatin-Based First-Line Therapy for Advanced Urothelial Carcinoma After Previous Perioperative Cisplatin-Based Therapy

Clinical Genitourinary Cancer
OncologyUrology
2015English

Triplet Chemotherapy With Paclitaxel, Gemcitabine, and Cisplatin as Second-Line Therapy for Advanced Urothelial Carcinoma

Modern Chemotherapy
2013English

Advanced Urothelial Carcinoma: Next-Generation Sequencing Reveals Diverse Genomic Alterations and Targets of Therapy

Modern Pathology
Forensic MedicinePathology
2013English

The Quest for an Ideal Neoadjuvant Systemic Therapy in Cisplatin‐Ineligible Patients With Muscle‐Invasive Localized Urothelial Carcinoma

Oncologist
Cancer ResearchMedicineOncology
2019English

Systemic Therapy for Advanced Kidney Cancer

Practical oncology
2019English

Update on Systemic Therapy for Advanced Soft Tissue Sarcoma

Current Oncology
Oncology
2020English

Bevacizumab Monotherapy as Salvage Therapy for Advanced Clear Cell Renal Cell Carcinoma Pretreated With Targeted Drugs

Clinical Genitourinary Cancer
OncologyUrology
2016English

Trends in Checkpoint Inhibitor Therapy for Advanced Urothelial Cell Carcinoma at the End of Life: Insights From Real‐World Practice

Oncologist
Cancer ResearchMedicineOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy